We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about malignant lymphoma, including its types (Hodgkin and non-Hodgkin), common symptoms like swollen lymph nodes, risk factors, diagnosis methods, and various treatment options.

Malignant lymphoma, often simply called lymphoma, is a type of cancer that originates in your lymphatic system. This system is a vital part of your body's immune defenses, working tirelessly to fight off infections and diseases. When lymphoma develops, it means certain white blood cells, specifically lymphocytes, have become abnormal and begin to multiply uncontrollably. These rogue cells can then form tumors and potentially spread to other parts of your body.
To understand lymphoma, it's helpful to know a bit about the lymphatic system. Think of it as a network of vessels and tissues spread throughout your body, much like your blood circulation system. This network includes:
The primary job of the lymphatic system is to produce lymphocytes (a type of white blood cell) and to help your body fight infections. When lymphoma occurs, these lymphocytes start to behave abnormally, leading to cancer.
Malignant lymphomas are broadly categorized into two main types:
Hodgkin lymphoma is distinguished by the presence of a specific abnormal cell called the Reed-Sternberg cell. This type of lymphoma is less common than non-Hodgkin lymphoma. Classic Hodgkin lymphoma accounts for the vast majority of cases, with a rarer form called nodular lymphocyte predominant Hodgkin disease making up a small percentage.
Non-Hodgkin lymphoma is a more diverse group, encompassing all other types of lymphoma that don't fit the criteria for Hodgkin lymphoma. There are many subtypes of NHL, with around 85% of cases involving B-cells (a type of lymphocyte). NHL can be further classified as either slow-growing (low-grade) or fast-growing (high-grade), depending on how quickly the cancer cells multiply.
It's important to remember that cancers originating in other parts of the body and spreading to the lymphatic system are not classified as lymphomas. Lymphoma itself is defined by its origin within the lymphatic system.
Symptoms of lymphoma can sometimes be subtle and easily mistaken for less serious conditions. However, certain signs warrant attention. The most common and noticeable symptom is the swelling of lymph nodes, often referred to as 'lymphadenopathy'. These swollen nodes typically feel firm and painless and can appear in various locations:
Beyond swollen lymph nodes, other potential symptoms include:
Real-life scenario: Consider a busy mother of two, Mrs. Sharma, who notices a small, firm lump in her armpit. She initially dismisses it, thinking it's from a recent strain. However, over a few weeks, she also starts feeling unusually tired and experiences night sweats that disrupt her sleep. These persistent symptoms prompt her to finally schedule a doctor's visit.
Doctors often cannot pinpoint a single cause for malignant lymphoma. However, several factors can increase an individual's risk of developing the condition:
It's important to understand that having one or more risk factors does not guarantee you will develop lymphoma. Many people with risk factors never get the disease, and some people diagnosed with lymphoma have no known risk factors.
Confirming a diagnosis of lymphoma involves a series of tests to identify the presence of cancer, determine the specific type and subtype, and assess its extent (stage). The diagnostic process typically includes:
Your doctor will ask about your symptoms, medical history, and perform a physical exam, paying close attention to any swollen lymph nodes.
These tests help assess your overall health, check blood cell counts, and look for any abnormalities that might suggest lymphoma or other conditions.
Scans like CT (Computed Tomography), MRI (Magnetic Resonance Imaging), and PET (Positron Emission Tomography) scans help doctors visualize enlarged lymph nodes or tumors within the body and determine if the cancer has spread.
This is the most definitive diagnostic tool. A small sample of an enlarged lymph node is removed (either through needle aspiration or surgical excision) and examined under a microscope by a pathologist. The biopsy confirms whether the cells are cancerous, identifies the specific type of lymphoma (Hodgkin vs. NHL), and helps determine the subtype.
The results from all these tests are combined to stage the lymphoma, which helps doctors plan the most effective treatment strategy.
The treatment approach for malignant lymphoma is highly individualized and depends on several factors, including:
Treatment therapies can be used alone or in combination. Common treatment modalities include:
Uses powerful drugs to kill cancer cells throughout the body. It can be administered orally or intravenously.
Uses high-energy rays to target and destroy cancer cells in a specific area of the body.
Helps your immune system recognize and fight cancer cells. This can involve drugs that stimulate your immune response or provide your body with cancer-fighting antibodies.
Focuses on specific abnormalities within cancer cells that help them grow and survive.
Involves high doses of chemotherapy and/or radiation, followed by the infusion of healthy blood-forming stem cells (either your own previously collected cells or donor cells) to restore bone marrow function.
For slow-growing lymphomas, doctors might recommend a
Overall, early action and medically verified advice remain the safest approach.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026